CANASA vs IXIFI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. CANASA and IXIFI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CANASA	IXIFI
Rating	72/100	64/100
Pharmacy pays	~$26.72 /30	—
Type	RX	RX
Active ingredient	MESALAMINE	INFLIXIMAB-QBTX
Manufacturer	Abbvie	Pfizer
Dosage forms	Suppository	Injectable
Drug class	Aminosalicylate	—
Boxed warning	None	None
Half-life	about 7 to 9 hours (apparent terminal half-life)	—
Treats	Ulcerative Colitis, Proctitis, Sigmoid Diseases	Rheumatoid Arthritis, Ulcerative Colitis, Crohn Disease

canasa ixifi

Rating

72/100

64/100

Pharmacy pays

~$26.72 /30

—

Type

Active ingredient

MESALAMINE

INFLIXIMAB-QBTX

Manufacturer

Abbvie

Pfizer

Dosage forms

Suppository

Injectable

Drug class

Aminosalicylate

—

Boxed warning

None

Half-life

about 7 to 9 hours (apparent terminal half-life)

—

Treats

Ulcerative Colitis, Proctitis, Sigmoid Diseases

Rheumatoid Arthritis, Ulcerative Colitis, Crohn Disease

Frequently asked questions

Which is better-rated, Canasa or Ixifi?

By our independent rating, Canasa scores higher — 3.6 vs 3.2 out of 5 for Ixifi. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Canasa and Ixifi?

Canasa contains Mesalamine, while Ixifi contains Infliximab-Qbtx — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.